<i>MED12</i>is recurrently mutated in Middle Eastern colorectal cancer
Abdul K. Siraj(King Faisal Specialist Hospital & Research Centre), Khawla S Al-Kuraya(King Faisal Specialist Hospital & Research Centre)
Cited by 16
Related Papers
ALK alteration is a frequent event in aggressive breast cancers
|Breast Cancer Research|2015|42
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation
|Cancers|2021|31
High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer
|OncoTargets and Therapy|2021|20
Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
|Frontiers in Pharmacology|2020|8
Loss of ZNF677 Expression Is an Independent Predictor for Distant Metastasis in Middle Eastern Papillary Thyroid Carcinoma Patients
|International Journal of Molecular Sciences|2021|8